Cost-effectiveness analysis of subcutaneous biosimilar tocilizumab in patients with rheumatoid arthritis in Spain Perez-Ruiz; Carlos Crespo-Diz; Joan Antoni Schoenenberger-Arnaiz; Mónica Cerezales; Carlos Crespo; Marcelo Alejandro Guigini; José Ignacio Peinado-Fabregat; Climente-Marti;

Baricitinib and tofacitinib in patients with rheumatoid arthritis: results of regular clinical practice Lara González-Freire; Rosa María Giménez-Candela; Susana Castro-Luaces; Ana Belén Veiga-Villaverde; Carlos Crespo-Diz;

Safety of biological disease-modifying antirheumatic drugs in rheumatoid arthritis Cristina Martínez-Múgica; Esther Salgueiro;